Cargando…
Correction: Overexpression of SMC4 activates TGFβ/Smad signaling and promotes aggressive phenotype in glioma cells
Autores principales: | Jiang, L., Zhou, J., Zhong, D., Zhou, Y., Zhang, W., Wu, W., Zhao, Z., Wang, W., Xu, W., He, L., Ma, Y., Hu, Y., Li, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674687/ https://www.ncbi.nlm.nih.gov/pubmed/36400761 http://dx.doi.org/10.1038/s41389-022-00442-2 |
Ejemplares similares
-
Overexpression of SMC4 activates TGFβ/Smad signaling and promotes aggressive phenotype in glioma cells
por: Jiang, L, et al.
Publicado: (2017) -
DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling
por: Chan, D W, et al.
Publicado: (2017) -
Correction for: Curcumin in combination with homoharringtonine suppresses lymphoma cell growth by inhibiting the TGF-β/Smad3 signaling pathway
por: Zhang, Yu, et al.
Publicado: (2022) -
TGF-β2 initiates autophagy via Smad and non-Smad pathway to promote glioma cells’ invasion
por: Zhang, Chao, et al.
Publicado: (2017) -
TGF-β1 secreted by M2 phenotype macrophages enhances the stemness and migration of glioma cells via the SMAD2/3 signalling pathway
por: Liu, Zhengzheng, et al.
Publicado: (2018)